首页> 美国卫生研究院文献>Acta Crystallographica Section F: Structural Biology and Crystallization Communications >Crystallization and preliminary crystallographic analysis of human aquaporin 1 at a resolution of 3.28 Å
【2h】

Crystallization and preliminary crystallographic analysis of human aquaporin 1 at a resolution of 3.28 Å

机译:水通道蛋白1的结晶和初步晶体学分析分辨率为3.28Å

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Aquaporin water channels (AQPs) are found in almost every organism from humans to bacteria. In humans, 13 classes of AQPs control water and glycerol homeostasis. Knockout studies have suggested that modulating the activity of AQPs could be beneficial for the treatment of several pathologies. In particular, aquaporin 1 is a key factor in cell migration and angiogenesis, and constitutes a possible target for anticancer compounds and also for the treatment of glaucoma. Here, a preliminary crystallographic analysis at 3.28 Å resolution of crystals of human aquaporin 1 (hAQP1) obtained from protein expressed in Sf9 insect cells is reported. The crystals belonged to the tetragonal space group I422, with unit-cell parameters a = b = 89.28, c = 174.9 Å, and contained one monomer per asymmetric unit. The hAQP1 biological tetramer is generated via the crystallographic fourfold axis. This work extends previous electron crystallo­graphic studies that used material extracted from human red blood cells, in which the resolution was limited to approximately 3.8 Å. It will inform efforts to improve lattice contacts and the diffraction limit for the future structure-based discovery of specific hAQP1 inhibitors.
机译:从人类到细菌,几乎所有生物体中都存在水通道水通道(AQP)。在人类中,有13类AQP控制着水和甘油的动态平衡。敲除研究表明,调节AQP的活性可能有益于多种病理学的治疗。特别地,水通道蛋白1是细胞迁移和血管生成中的关键因素,并且构成抗癌化合物和青光眼治疗的可能靶标。在此,报道了从Sf9昆虫细胞中表达的蛋白质获得的人水通道蛋白1(hAQP1)晶体在3.28分辨率下的初步晶体学分析。晶体属于四方晶空间群I422,晶胞参数a = b = 89.28,c = 174.9,每个不对称单元包含一个单体。 hAQP1生物四聚体是通过晶体学四重轴生成的。这项工作扩展了以前的电子晶体学研究,该研究使用的是从人红细胞中提取的物质,其分辨率限于约3.8Å。它将为改善晶格接触和衍射极限提供信息,以用于将来基于结构的特定hAQP1抑制剂的发现。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号